Journal issue - WANFANG MED ONLINE

You Position: Home > Journal issue

Journal of Leukemia & Lymphoma

Issue 2, 2022

Items 1-5 of 16

«Preious | of 4 | Next»

Progress in molecular resistance mechanisms of targeted therapy for chronic myeloid leukemia

Journal of Leukemia and Lymphoma, Volume 31, Issue 2,2022, Pages 73-76, doi:10.3760/cma.j.cn115356-20211216-00296

Status and prospect of reproductive protection in patients with lymphoma

Journal of Leukemia and Lymphoma, Volume 31, Issue 2,2022, Pages 77-82, doi:10.3760/cma.j.cn115356-20210707-00151

Observation on the efficacy of liposomal doxorubicin intensive preconditioning regimen and allogeneic hematopoietic stem cell transplantation for treatment of leukemia

Journal of Leukemia and Lymphoma, Volume 31, Issue 2,2022, Pages 96-98, doi:10.3760/cma.j.cn115356-20201120-00281

Observation on the efficacy of CLAG regimen in treatment of relapsed/refractory acute myeloid leukemia

Journal of Leukemia and Lymphoma, Volume 31, Issue 2,2022, Pages 92-95, doi:10.3760/cma.j.cn115356-20210826-00199

Progress of autologous hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy for treatment of relapsed/refractory large B-cell lymphoma

Journal of Leukemia and Lymphoma, Volume 31, Issue 2,2022, Pages 65-67, doi:10.3760/cma.j.cn115356-20220101-00001

Items 1-5 of 16

«Preious | of 4 | Next»

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

2003:

2002:

2001:

2000: